| Product Code: ETC13311401 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Deep Brain Stimulation Parkinsons Disease Market was valued at USD 2 Billion in 2024 and is expected to reach USD 4.5 Billion by 2031, growing at a compound annual growth rate of 8.30% during the forecast period (2025-2031).
The Global Deep Brain Stimulation Parkinson`s Disease Market is experiencing significant growth driven by an increasing prevalence of Parkinson`s disease worldwide. Deep brain stimulation is a highly effective treatment option for managing motor symptoms in Parkinson`s patients, leading to a rising demand for this therapy. Technological advancements in DBS devices, such as improved battery life and programming capabilities, are further propelling market growth. Key players in the market are investing in research and development to enhance the efficacy and safety of DBS systems, expanding their product portfolios. North America dominates the market due to high healthcare expenditure and a large patient population. However, the Asia-Pacific region is expected to witness rapid growth due to improving healthcare infrastructure and increasing awareness about Parkinson`s disease treatment options.
The Global Deep Brain Stimulation Parkinson`s Disease Market is witnessing significant growth due to the rising prevalence of Parkinson`s disease worldwide. Key trends include the development of advanced DBS devices with improved targeting and programming capabilities, as well as increased adoption of minimally invasive surgical techniques for implanting DBS devices. Opportunities in the market lie in expanding applications of DBS beyond Parkinson`s disease, such as in treating other movement disorders and psychiatric conditions. Additionally, the market is expected to benefit from ongoing research initiatives focused on enhancing the efficacy and safety of DBS therapy. Overall, the Global DBS Parkinson`s Disease Market is poised for continued growth driven by technological advancements and expanding therapeutic indications.
The Global Deep Brain Stimulation Parkinson`s Disease Market faces several challenges, including high costs associated with the procedure and device, limited accessibility in developing countries, and the need for specialized healthcare professionals to perform the surgery and manage patient care post-implantation. Additionally, there is a lack of long-term data on the efficacy and safety of deep brain stimulation for Parkinson`s disease, leading to uncertainties among patients and healthcare providers. Regulatory hurdles and reimbursement issues further complicate market expansion. Moreover, the competitive landscape continues to evolve with new entrants introducing innovative technologies, increasing competition for market share. Overall, navigating these challenges requires continuous innovation, investment in research and development, strategic partnerships, and a patient-centric approach to drive growth in the Global Deep Brain Stimulation Parkinson`s Disease Market.
The Global Deep Brain Stimulation Parkinson`s Disease Market is primarily driven by the increasing prevalence of Parkinson`s disease worldwide, leading to a growing demand for effective treatment options. Technological advancements in deep brain stimulation devices, such as improved electrode designs and programming algorithms, are also fueling market growth by enhancing treatment outcomes and patient comfort. Additionally, rising awareness about the benefits of deep brain stimulation therapy among healthcare professionals and patients is contributing to market expansion. Moreover, favorable reimbursement policies for deep brain stimulation procedures in many countries are further propelling market growth by making the treatment more accessible to a larger patient population. Overall, these factors are driving the growth of the Global Deep Brain Stimulation Parkinson`s Disease Market.
Government policies related to the Global Deep Brain Stimulation Parkinson`s Disease Market focus on promoting accessibility, affordability, and innovation in healthcare services. Many governments have implemented reimbursement schemes to cover the costs of deep brain stimulation procedures for Parkinson`s Disease patients, making the treatment more accessible to a wider population. Additionally, regulatory bodies have established guidelines to ensure the safety and effectiveness of deep brain stimulation devices, thereby fostering innovation in the market. Governments also support research and development initiatives in the field of neurological disorders, encouraging collaboration between public and private sectors to drive advancements in treatment options for Parkinson`s Disease. Overall, government policies aim to improve patient outcomes, enhance quality of life, and address the growing burden of Parkinson`s Disease on healthcare systems globally.
The Global Deep Brain Stimulation Parkinson`s Disease Market is poised for significant growth in the coming years due to the rising prevalence of Parkinson`s disease worldwide and the increasing adoption of deep brain stimulation as an effective treatment option. Technological advancements in deep brain stimulation devices, coupled with ongoing research and development activities to enhance treatment efficacy and outcomes, are expected to drive market expansion. Additionally, the growing geriatric population, which is more susceptible to Parkinson`s disease, will further fuel market growth. With a focus on improving patient outcomes and quality of life, key market players are investing in innovation and product development to address unmet medical needs and capitalize on the expanding market opportunities.
In the Global Deep Brain Stimulation Parkinson`s Disease Market, Asia is expected to witness the fastest growth due to increasing healthcare infrastructure and rising awareness about neurological disorders. North America holds a significant market share, driven by the presence of key market players and high adoption of advanced medical technologies. Europe is also a prominent market, with a growing prevalence of Parkinson`s disease and supportive government initiatives for disease management. In the Middle East and Africa region, the market is expanding gradually, supported by improving healthcare facilities and rising investments in research and development. Latin America is experiencing steady growth, attributed to increasing healthcare expenditure and a growing geriatric population prone to Parkinson`s disease. Overall, the global market for Deep Brain Stimulation in Parkinson`s Disease is poised for substantial growth across all regions.
Global Deep Brain Stimulation Parkinsons Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Deep Brain Stimulation Parkinsons Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global Deep Brain Stimulation Parkinsons Disease Market - Industry Life Cycle |
3.4 Global Deep Brain Stimulation Parkinsons Disease Market - Porter's Five Forces |
3.5 Global Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.7 Global Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume Share, By Power Source, 2021 & 2031F |
3.9 Global Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Deep Brain Stimulation Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Deep Brain Stimulation Parkinsons Disease Market Trends |
6 Global Deep Brain Stimulation Parkinsons Disease Market, 2021 - 2031 |
6.1 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Device Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Single Channel, 2021 - 2031 |
6.1.3 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Dual Channel, 2021 - 2031 |
6.2 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.3 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.2.4 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Power Source, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Rechargeable, 2021 - 2031 |
6.3.3 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Non-Rechargeable, 2021 - 2031 |
6.4 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Direct, 2021 - 2031 |
6.4.3 Global Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distributors, 2021 - 2031 |
7 North America Deep Brain Stimulation Parkinsons Disease Market, Overview & Analysis |
7.1 North America Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4 North America Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Power Source, 2021 - 2031 |
7.6 North America Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Deep Brain Stimulation Parkinsons Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Device Type, 2021 - 2031 |
8.4 Latin America (LATAM) Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Power Source, 2021 - 2031 |
8.6 Latin America (LATAM) Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Deep Brain Stimulation Parkinsons Disease Market, Overview & Analysis |
9.1 Asia Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Device Type, 2021 - 2031 |
9.4 Asia Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Power Source, 2021 - 2031 |
9.6 Asia Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Deep Brain Stimulation Parkinsons Disease Market, Overview & Analysis |
10.1 Africa Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Device Type, 2021 - 2031 |
10.4 Africa Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Power Source, 2021 - 2031 |
10.6 Africa Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Deep Brain Stimulation Parkinsons Disease Market, Overview & Analysis |
11.1 Europe Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Device Type, 2021 - 2031 |
11.4 Europe Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Power Source, 2021 - 2031 |
11.6 Europe Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Deep Brain Stimulation Parkinsons Disease Market, Overview & Analysis |
12.1 Middle East Deep Brain Stimulation Parkinsons Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Device Type, 2021 - 2031 |
12.4 Middle East Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Power Source, 2021 - 2031 |
12.6 Middle East Deep Brain Stimulation Parkinsons Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Deep Brain Stimulation Parkinsons Disease Market Key Performance Indicators |
14 Global Deep Brain Stimulation Parkinsons Disease Market - Export/Import By Countries Assessment |
15 Global Deep Brain Stimulation Parkinsons Disease Market - Opportunity Assessment |
15.1 Global Deep Brain Stimulation Parkinsons Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Deep Brain Stimulation Parkinsons Disease Market Opportunity Assessment, By Device Type, 2021 & 2031F |
15.3 Global Deep Brain Stimulation Parkinsons Disease Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Deep Brain Stimulation Parkinsons Disease Market Opportunity Assessment, By Power Source, 2021 & 2031F |
15.5 Global Deep Brain Stimulation Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Deep Brain Stimulation Parkinsons Disease Market - Competitive Landscape |
16.1 Global Deep Brain Stimulation Parkinsons Disease Market Revenue Share, By Companies, 2024 |
16.2 Global Deep Brain Stimulation Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here